Skip to content

Clinical trials

Phase 2 Coronary Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Disease Phase: Phase 2 Clear all

79 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20021
20031
20043
20054
20065
20073
20086
20102
20115
20124
20132
20142
20152
20162
20174
20183
20203
20231
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed60
Unknown status9
Terminated4
Withdrawn2
Recruiting2
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)12
Hoffmann-La Roche5
Merck Sharp & Dohme LLC2
National Center for Complementary and Integrative Health (NCCIH)2
Novartis Pharmaceuticals2
Sanofi2
ARCA Biopharma, Inc.1
Abbott Medical Devices1
Affiliated Hospital of Changchun University of Chinese Medicine1
Affiliated Hospital of Nantong University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Disease79
Coronary Artery Disease21
Myocardial Ischemia19
Heart Diseases15
Cardiovascular Diseases12
Myocardial Infarction9
Atherosclerosis6
Acute Coronary Syndrome5
Vascular Diseases5
Angina Pectoris4

Trials

Showing 51 to 75 of 79. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.